Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to sign a consent form agreeing to take part in the study
- People who are willing to follow all study procedures and are available for the full length of the study
- Men or women between the ages of 18 and 95 at the time of signing the consent form
- People who have been diagnosed with either Type 1 or Type 2 diabetes
- People who have a diabetic foot wound located on the ankle or lower part of the leg that has been present for at least 3 months before the screening visit
- People whose wound has been rated at a severity level of 2 or higher using a standard wound grading scale called the Wagner grading system
- People whose wound measures at least 2 cm² in size after any wound cleaning or removal of dead tissue
- People who have adequate blood flow to the affected limb, confirmed through a specific blood flow measurement or other documented medical evidence
- People (or their caregivers) who are willing and able to learn how to change wound dressings at home
- Women who are able to become pregnant and who have been using a highly effective form of contraception for at least one month before screening, and who agree to continue doing so throughout the study
Who may not be able to join:
- People who currently have an active cancer diagnosis
- People who have low levels of haemoglobin in their blood (confirm with trial site)
- People who are scheduled to have vascular surgery, a procedure to open blocked blood vessels, or a clot-dissolving treatment at the time they would join the trial
- People who have a history of cancer affecting the leg involved in the study, or who have received radiation or chemotherapy treatment within 3 months before joining the trial
- People who are currently taking medication that suppresses the immune system
- People who have received certain wound growth factor therapies within two weeks before screening (confirm with trial site for specific treatments)
- People whose long-term blood sugar levels are very poorly controlled, specifically an HbA1c result above 12%
- People with a documented history of alcohol or substance misuse within 6 months before screening
- People who are currently enrolled in, or have participated in, another clinical trial involving a drug, device, or biological treatment within 30 days before screening
- People who are pregnant at the time of screening
- People who already own a low-level laser (photobiomodulation) device at home
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rose Raizman, MSc, MScN, Scarborough Health Network
Phone: +1-416-8862328
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of complete (100%) wound closure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.